We recently described that in addition to growth factor receptors, hypoxia upregulated proteins (carbonic anhydase IX (CAIX) and XII (CAXII), and GLUT1) and CD44 variants might be useful for molecular imaging of female breast cancer [24]. This evidence concerns the gene CA9 and breast carcinoma.